Abcam Reports & Presentations

2017 Reports

Annual report for the year ending 30 June 2017
Preliminary results for year ending June 2017
Interim report for half-year ending 31 Dec 2016
35th Annual JP Morgan Healthcare Conference webcast

2016 Reports

Preliminary results for year ending 30 June 2016
Interim report for half-year ending 31 Dec 2015

2015 Reports

Preliminary results for year ending 30 June 2015
Interim report for half-year ending 31 Dec 2014

2014 Reports

Preliminary results for year ending 30 June 2014
Interim report for half-year ending 31 Dec 2013

2013 Reports

Preliminary results for year ending 30 June 2013
Interim report for half-year ending 31 Dec 2012

2012 Reports

Preliminary results for year ending 30 June 2012
Interim results for half-year ending 31 Dec 2011

2011 Reports

Preliminary results for year ending 30 June 2011
Interim results for half-year ending 31 Dec 2010

2010 Reports

Preliminary results for year ending 30 June 2010
Interim results for half-year ending 31 Dec 2009

2009 Reports

Preliminary results for year ending 30 June 2009
Interim results for half-year ending 31 Dec 2008

2008 Reports

Preliminary results for year ending 30 June 2008
Interim results for half-year ending 31 Dec 2007

2007 Reports

Preliminary results for year ending 30 June 2007
Interim results for half-year ending 31 Dec 2006

2006 Reports

Preliminary results for year ending 30 June 2006
Interim results for half-year ending 31 Dec 2005

2005 Reports

Preliminary results for year ending 30 June 2005

About Abcam

Abcam is a producer and marketer of high quality protein research tools. These tools enable life scientists to analyse components of living cells at the molecular level which is essential in a wide range of fields including drug discovery, diagnostics, and basic research.

Read more +

Abcam Products

As an innovator in reagents and tools, Abcam offers highly validated binders and assays to address important targets in critical biological pathways.

Read more +

Investor Information

Abcam is listed on the AIM market of the London Stock Exchange under the ticker ABC, and our investors' centre includes a range of information on our company, including our news, financial reports and investor contacts

Read more +

Abcam News

We provide updates on our commercial and financial progress through regular press releases which can be accessed through the Company's media centre.

Read more +